Articles published by AngioDynamics, Inc.

< Previous 1 2 3 Next >

AngioDynamics Reports Fiscal Year 2024 Second Quarter Financial Results; Revises Fiscal Year 2024 Guidance

January 05, 2024

From AngioDynamics, Inc.

Via Business Wire

Tickers ANGO

AngioDynamics to Present at the J.P. Morgan Healthcare Conference

December 21, 2023

From AngioDynamics, Inc.

Via Business Wire

Tickers ANGO

AngioDynamics to Report Fiscal 2024 Second Quarter Financial Results on January 5, 2024

December 07, 2023

From AngioDynamics, Inc.

Via Business Wire

Tickers ANGO

AngioDynamics Completes Patient Enrollment in APEX-AV Study Assessing AlphaVac F1885 System in Treatment of Pulmonary Embolism

December 07, 2023

From AngioDynamics, Inc.

Via Business Wire

Tickers ANGO

AngioDynamics Reports Fiscal Year 2024 First Quarter Financial Results; Reaffirms Fiscal Year 2024 Guidance

October 04, 2023

From AngioDynamics, Inc.

Via Business Wire

Tickers ANGO

AngioDynamics to Report Fiscal 2024 First Quarter Financial Results on October 4, 2023

September 12, 2023

From AngioDynamics, Inc.

Via Business Wire

Tickers ANGO

AngioDynamics Receives FDA Breakthrough Device Designation for the AngioVac System for the Non-Surgical Removal of Right Heart Vegetation

August 15, 2023

From AngioDynamics, Inc.

Via Business Wire

Tickers ANGO

AngioDynamics Completes Enrollment for PRESERVE Clinical Study

August 03, 2023

From AngioDynamics, Inc.

Via Business Wire

Tickers ANGO

AngioDynamics to Participate in a Fireside Chat at the Canaccord Genuity Growth Conference

July 31, 2023

From AngioDynamics, Inc.

Via Business Wire

Tickers ANGO

AngioDynamics Announces Addition of Lorinda Burgess to Board of Directors

July 24, 2023

From AngioDynamics, Inc.

Via Business Wire

Tickers ANGO

AngioDynamics Reports Fiscal Year 2023 Fourth Quarter and Full-Year Financial Results; Issues Fiscal Year 2024 Guidance

July 12, 2023

From AngioDynamics, Inc.

Via Business Wire

Tickers ANGO

AngioDynamics to Report Fiscal 2023 Fourth Quarter and Full-Year Financial Results on July 12, 2023

June 20, 2023

From AngioDynamics, Inc.

Via Business Wire

Tickers ANGO

AngioDynamics Announces Sale of Dialysis Product Portfolio and BioSentry Product to Merit Medical Systems for $100 Million

June 08, 2023

From AngioDynamics, Inc.

Via Business Wire

Tickers ANGO

AngioDynamics to Present at the Needham Virtual Healthcare Conference

April 11, 2023

From AngioDynamics, Inc.

Via Business Wire

Tickers ANGO

AngioDynamics Reports Fiscal 2023 Third Quarter Financial Results; Revises Guidance

March 30, 2023

From AngioDynamics, Inc.

Via Business Wire

Tickers ANGO

AngioDynamics to Report Fiscal 2023 Third Quarter Financial Results on March 30, 2023

March 13, 2023

From AngioDynamics, Inc.

Via Business Wire

Tickers ANGO

AngioDynamics to Participate in Three Investor Conferences in March

February 28, 2023

From AngioDynamics, Inc.

Via Business Wire

Tickers ANGO

AngioDynamics Reports Fiscal 2023 Second Quarter Financial Results; Reaffirms Guidance

January 05, 2023

From AngioDynamics, Inc.

Via Business Wire

Tickers ANGO

AngioDynamics to Present at the J.P. Morgan Healthcare Conference

December 20, 2022

From AngioDynamics, Inc.

Via Business Wire

Tickers ANGO

AngioDynamics to Report Fiscal 2023 Second Quarter Financial Results on January 5, 2023

December 15, 2022

From AngioDynamics, Inc.

Via Business Wire

Tickers ANGO

AngioDynamics to Present at the Piper Sandler Healthcare Conference

November 17, 2022

From AngioDynamics, Inc.

Via Business Wire

Tickers ANGO

AngioDynamics Announces First Patient Enrolled in APEX-AV Study Assessing AlphaVac F1885 PE System in Treatment of Pulmonary Embolism

October 31, 2022

From AngioDynamics, Inc.

Via Business Wire

Tickers ANGO

AngioDynamics Reports Fiscal 2023 First Quarter Financial Results; Reaffirms Guidance

October 06, 2022

From AngioDynamics, Inc.

Via Business Wire

Tickers ANGO

AngioDynamics to Report Fiscal 2023 First Quarter Financial Results on October 6, 2022

September 08, 2022

From AngioDynamics, Inc.

Via Business Wire

Tickers ANGO

AngioDynamics to Present at the Canaccord Genuity Growth Conference

August 03, 2022

From AngioDynamics, Inc.

Via Business Wire

Tickers ANGO

AngioDynamics Reports Fiscal Year 2022 Fourth Quarter and Full-Year Financial Results; Issues Fiscal Year 2023 Guidance

July 12, 2022

From AngioDynamics, Inc.

Via Business Wire

Tickers ANGO

AngioDynamics to Report Fiscal 2022 Fourth Quarter and Full-Year Financial Results on July 12, 2022

June 15, 2022

From AngioDynamics, Inc.

Via Business Wire

Tickers ANGO

AngioDynamics to Present at the UBS Global Healthcare Conference

May 16, 2022

From AngioDynamics, Inc.

Via Business Wire

Tickers ANGO

AngioDynamics to Present at the BofA Securities Healthcare Conference

May 03, 2022

From AngioDynamics, Inc.

Via Business Wire

Tickers ANGO

AngioDynamics Reports Fiscal 2022 Third Quarter Financial Results; Reaffirms Fiscal Year 2022 Guidance

April 07, 2022

From AngioDynamics, Inc.

Via Business Wire

Tickers ANGO

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.